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On Preparing a List of Random Treatment Assignments:
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Abstract - This paper presents the foundations of a computer oriented approach for
preparing a list of random treatment assignments to be adopted in randomised
controlled trials. Software is presented which can be applied in the earliest stage of
clinical trials and bioequivalence assays. This allocation of patients to treatment in
clinical trials ensures exactly equal treatment numbers. The investigation of the
randomness properties of an assignment leads to the concept of a "strong
randomised list". The new approach introduced in this note is based on thresholds
and produces a strong randomised list of treatment assignments.
1. INTRODUCTION
The Pharmaceutical industry has had a huge interest in organising trials to resolve
relevant therapeutic aspects. Clinical trials play a very important role in the
evaluation of new issues for drug therapy. Statistics is not only decisive in data
analysis but also beforehand the study's design of a trial. It has long been recognised
that uncontrolled trial potentially provide distorted outcome of the therapy. In contrast,
clinical trials with a properly randomised control groups avoid bias and provide a
basis for statistical tests. One essential is that clinician must be unable to predict what
the assignment will be. Simple randomisation, replacement randomisation, biased
coin method and random permuted blocks are some approaches normally adopted to
generate a list of assignments1-5. This paper presents a computer-oriented approach
for preparing a random list of treatment assignments. Statistical properties of
randomisation lists are also examined.
2. THE RANDOMIZATION LIST GENERATION
The use of a software to produce lists based on a computer generated sequence of
pseudo-random numbers6 is a fully convenient tool for staffs extensively involved in
clinical trials. Properly randomised control groups avoid drawbacks of the simple
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2randomisation and the replacement randomisation1-4. It is therefore helpful to design
randomisation to ensure similar treatment numbers throughout a trial. The computer
generation of a random assignment introduced in this paper is based on an internal
(0,1)-uniform distributed random number generator6. The list can be used one at a
time as patients are registered into the trial. Some care should be taken to avoid
repeating the same output list by assuring different lists of assignments in each
program run. A clock-dependent seed must therefore be adopted. Let N be the
number of patients registered into the trial and let g denote the number of patient
groups. U denotes the uniformed-distributed random variable. The procedure is
flexible allowing an experiment design for any number of patients and any number of
groups with an equal number of patients provided that g divides N. The approach is
founded on a choice of a threshold set {T1,T2,T3...,TN}. The key point is that the
random sampling is made without reposition. Two lists (vectors) are then considered:
i) A list L of assignments L ={L1,L2,L3,...,LN} and
ii) A list S of survivors S ={S1,S2,S3,...,SN}.
The procedure begins with an empty list of assignments, L ={ }, and a full list of
survivors, S ={1,2,3,...,N}. Pick up then the first random number U1. Setting the
thresholds as Tk=k/N, a patient number k is chosen if and only if Tk-1  U1<Tk.
Therefore k is included into the list L , i.e., L1k (the mean of Lk being the usual
in computer languages: assign the value k to the variable L). Thus, the probability of
selecting a particular patient number k is uniformed distributed, P(k)=1/N (k).
Since the random sample must be taken with no reposition, the patient number k must
be deleted in the survivor list S . This circumvents considering the index k in the next
step. The likelihood of selecting an arbitrary patient number (except k) must be up-
dated using conditional probabilities since that the sample space had changed7. The
thresholds are adjusted to be now Tk=k/(N-1), k=1,2,...,N-1. A new choice of the list
is done by a second random guess U2, proceeding a comparison with the up-dated set
of thresholds. The procedure goes on in a similar way in each new step and the
thresholds for the Ith-step are Tk=k/|| S
 ||. The probability of selecting a particular
patient number k is uniformed distributed and the conditional probability
P(k| S )=P(Tk-1UI<Tk | S )= 1/|| S || so that the following algorithm is established:
33. THE THRESHOLD-BASED ALGORITHM
BEGIN
P1. Read N and g. If g | N continue else enter data again
(g | N denotes g divides N).
P2. Set initial conditions: I=0, Li=0, Si=i (i=1,N), i.e.
L ={0,0,0,...,0} and S ={1,2,3,...,N}.
P3. WHILE I<N DO
BEGIN
P3.1. Threshold up dating: Tk  kN  I , k=0,1,2,...,N-I.
(There is exactly N-I thresholds)
P3.2. Next step: II+1.
P3.3. Pick up the Ith-uniform random number U.
P3.4. If Tk1 UI  Tk (k=1,2,...,N-I) the k must be included
in the random list L , that is, LIk.
P3.5. Up-date (shrink) the survivor list.
(*Since the random list should have no repetition,
k must be deleted from the survivor list.*)
END;
P4. FOR m equal 1 to g:
Print the group number and their corresponding elements;
END.
After the random generation of the list L , it is divided into g groups namely
G1  {L1,L2, ... ,LN / g}, G2  {LN / g +1,LN / g + 2, .. .,L2 N/ g} , ..., Gg  {LN N / g +1,. ..,LN 1,LN}
each of them with cardinality ||Gi||=N/g i=1,2,3...,g.
A naive illustrative example is presented in the sequel showing how to design a
simple randomised trial with 12 patients and 2 treatments.
Random number list of assignments L survivor list S
U1=0.168502561... L={3} S={1,2,4,5,6,7,8,9,10,11,12}
U2=0.658033330... L={3,9} S={1,2,4,5,6,7,8,10,11,12}
U3=0.093729293... L={3,9,1} S={2,4,5,6,7,8,10,11,12}
U4=0.756609143... L={3,9,1,10} S={2,4,5,6,7,8,11,12}
U5=0.463955829... L={3,9,1,10,6} S={2,4,5,7,8,11,12}
U6=0.070162761... L={3,9,1,10,6,5} S={2,4,7,8,11,12}
U7=0.222246588... L={3,9,1,10,6,5,11} S={2,4,7,8,12}
U8=0.706319757... L={3,9,1,10,6,5,11,8} S={2,4,7,12}
U9=0.586996776... L={3,9,1,10,6,5,11,8,12} S={2,4,7}
U10=0.752142819... L={3,9,1,10,6,5,11,8,12,7} S={2,4}
U11=0.937703174... L={3,9,1,10,6,5,11,8,12,7,4} S={2}
U12=0.669782608... L={3,9,1,10,6,5,11,8,12,7,4,2} S={ }
4Threshold calculations:
T[1] T[2] T[3] T[4] T[5] T[6] T[7] T[8] T[9] T[10] T[11] T[12]
0.0833 0.0166 0.25 0.33 0.4166 0.5 0.5833 0.66 0.75 0.833 0.9166 1.00
0.090 0.18 0.27 0.36 0.45 0.54 0.63 0.72 0.81 0.90 1.00
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.00
0.11 0.22 0.33 0.44 0.55 0.66 0.77 0.88 1.00
0.125 0.25 0.375 0.5 0.625 0.75 0.875 1.00
...
...
0.5 1.00
1.00
The Ith set of threshold is given by T[k]=k/(12-I), k=1,2,...,12-I and the underline
denotes an infinite repetition, e.g. 0.0833=0.08333333333...
For instance, the 4th patient assignment depends only on U4=0.756609143... The
survivor list prior this step is S ={2,4,5,6,7,8,10,11,12}. Since that
T[6]=0.66  U4<T[7]=0.77 the 7th element of the survivor list is selected: Insert
number 10 in the list of assignments and up-date the survivor list by erasing such a
patient number: S ={2,4,5,6,7,8,11,12}.
The treatment (A or B) is decided after obtaining the complete list of assignments:
L ={3,9,1,10,6,5,11,8,12,7,4,2}.
Treatment A: The first N/g=6 patients;
Treatment B: The last N/g=6 patients of the list L .
4. EXAMINING THE RANDOMNESS OF A LIST OF ASSIGNMENTS
The following propositions corroborate that the threshold-based approach achieves
properly randomised groups. The symbols  and  denote the union and intersection
of events, respectively.
Proposition 1. An arbitrary patient (say number k) has exactly the same probability
to be in any position of the list of assignments, that is,
P(Li  k)  1N    (k  1,2,.. .,N),   (i  1,2,. ..N ) . 
Proof. Since that U is a uniform random variable, P(L1=k)=P(0<U1<1/N)= 1N . It is
worthwhile to remark then that P(L2  k)  P(L2  k L1  k) so that
P(L2  k)  P(L1  k)P(L2  k|L1  k) = N 1N
1
N 1 
1
N .
Following, the probability of the patient number k be assigned in the 3rd position of
5the list is evaluated: P(L3  k)  P(L3  k L1  k L2  k) . Therefore,
P(L3  k)  P(L1  k)P(L2  k|L1  k)P(L3  k|L1  k,L2  k)=
N 1
N
N  2
N 1
1
N  2 
1
N . By using a similar reasoning, it can be proved that
P(L4  k)  N 1N
N  2
N 1
N  3
N  2
1
N  3 
1
N and the proof is completed by induction
QED.
Proposition 2. An arbitrary patient has exactly the same probability to be in a
treatment, no matter which the treatment is. 
Proof. Let us consider an arbitrary treatment, say m. The set Gm is the list of patients
under the treatment m, 1mg. The probability of the kth patient be assigned to such a
treatment is given by
g
Nm
g
Nmi
im kLPGkP
.
1)1(
) }{    ()(

 . Since the events are mutually exclusive, it follows
that P(k Gm )    P(Li  k)
i (m1) Ng 1
m.Ng . Using proposition 1 completes the proof:
P(k Gm )    1Ni (m1) Ng 1
m.Ng = ||Gm || 1N  Ng 1N  1g . QED.
For a number of g treatments, a number of g random groups are firstly generated. The
clinical trial involves g phases designed in such a way that each group is submitted to
all the g treatments, one at a time. The randomisation list of consecutive random
treatments must now be generated. In other words, after defining the patients groups
by the threshold approach, it is required to decide which treatment must be
administrated to each group, on each study phase (phase 1,2, ..., g). The threshold
method is called once more so as to find the phase-I (random) assignment. Simply
considering all cyclic permutations8 of the first assignment for phase-I can complete
the design of the next phases. A g  g matrix [G] is defined in which the phase-I
assignment fulfil the first row. The other rows are cyclic permutations of the first row,
so the elements of such matrix can be computed in terms of the first row elements
according to:
G(i,j)=G(1, { i(j) } MOD g), i=2,3,...,g and j=1,2,3,...,g
6Where

  otherwise.  g, MOD 1)-(i-j
1-ij                      )( gji
The operation "MOD g" denotes the classical modulo g reduction8.
The final list of the random trial assignment is given by the matrix:
[G] =










),()2,()1,(
),2()2,2()1,2(
),1()2,1()1,1(
ggGgGgG
gGGG
gGGG




On the phase i, the group G(i,j) is submitted to the treatment number j. As an example,
a 4-treatment case is considered in the sequel. If the four uniform distributed random
variables at the output of the threshold assignment furnishes U1=0.6531...U2=0.1497...
U3=0.7121... U4=0.2437..., then the assignment list will be:
1/2U1<3/4 L ={3}
0U2<1/3 L ={3,1}
1/2U3<1 L ={3,1,4}
0U4<1 L ={3,1,4,2}.
Therefore, the phase-I assignment is 3 1 4 2, which means: Group #3: treatment 1;
Group #1: treatment 2; Group #4: treatment 3; Group #2: treatment 4. All the cyclic
permutations of the phase-I assignment are now generated yielding a 44 matrix:
treatment










3241
1324
4132
2413
phase
Thus, on the phase II, the group 2 is submitted to treatment 1, the group 3 is
submitted to treatment 2 and so on.
Proposition 3. The probability of an arbitrary treatment be assigned to any group at
any phase is exactly the same. 
Proof. The probability of the mth group be assigned to the jth treatment on the phase i
is P(G(i,j)=m). On the other hand, since that the phase I assignment was derived from
the threshold approach, it follows that
j)(      1)),1((  gmjGP .
Remembering now that cyclic permutations were used to derive the phase-i
7assignment, i>1, then:
 mgMODjGPmjiGP i  )  )}({ ,1()),((  .
Therefore, given an arbitrary group Gm, the probability of Gm being selected for any
treatment j is the same, no matter the phase, i.e.
m)(  j)(  i)(   1)),((  gmjiGP . QED.
The randomisation list is finally transferred to a sequence of sealed envelopes. Indeed
it is supposed that no information at all on groups' order should be furnished,
otherwise such knowledge could be used and the conditional probabilities will be:

    otherwise.           0
,))(,1(m if  1)),1(),...1,1(|))(,1(()),1(),...1,1(|),(( jGgGGmjGPgGGmjiGP ii

for i2, that is, the next phase assignments will be deterministic.
Finally, the following concept in the random lists design is introduced:
Definition. A randomisation list of consecutive random treatments prepared in such a
way that Propositions 1 to 3 hold is defined as a strong randomisation assignment. 
5. DISCUSSION
Clinical trials are one of the most adopted strategies in the evaluation of new issues
for drug therapy. A computer-aided approach for preparing a list of random treatment
assignments is offered as a tool for groups extensively involved in such trials. This
way of patients' selection ensures exactly equal treatment numbers. The technique,
referred as to the "threshold approach", is general and can be applied for a
randomised trial with any number of treatments. It can also easily be extended to
stratified randomisation. Aiming to avoid that clinician "breaks the code" no
information on the groups' order must be furnished in the final list. The randomness
of the patient's allocation to treatment is examined showing that a "strong
randomisation" is achieved. Freeware software for preparing a randomisation list is
available on request at hmo@ufpe.br.
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